Literature DB >> 22205786

Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases.

Kentaro Oka1, Takako Osaki, Tomoko Hanawa, Satoshi Kurata, Mitsuhiro Okazaki, Taki Manzoku, Motomichi Takahashi, Mamoru Tanaka, Haruhiko Taguchi, Takashi Watanabe, Takashi Inamatsu, Shigeru Kamiya.   

Abstract

In this study, we investigated the correlation between the microbiological characteristics of Clostridium difficile clinical isolates and the recurrence of C. difficile-associated disease (CDAD). Twenty C. difficile isolates recovered from 20 single infection cases and 53 isolates from 20 recurrent cases were analyzed by pulsed-field gel electrophoresis (PFGE) and PCR ribotyping, and the cytotoxicity, antimicrobial susceptibility, and sporulation/germination rates of the isolates were examined. Recurrent cases were divided into relapse or reinfection cases by the results of C. difficile DNA typing. Among the 20 recurrent cases, 16 cases (80%) were identified to be relapse cases caused by the initial strain and the remaining 4 cases (20%) were identified to be reinfection cases caused by different strains. All 73 isolates were susceptible to both vancomycin and metronidazole, but resistance against clindamycin, ceftriaxone, erythromycin, and ciprofloxacin was found in 87.7%, 93.2%, 87.7%, and 100% of the isolates, respectively. No correlations between DNA typing group, cytotoxicity, and sporulation rate of isolates and infection status, i.e., single, relapse, or reinfection, were observed. However, the isolates recovered from relapse cases showed a significantly higher germination rate when incubated in medium lacking the germination stimulant sodium taurocholate. These results indicate that the germination ability of C. difficile may be a potential risk factor for the recurrence of CDAD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22205786      PMCID: PMC3295180          DOI: 10.1128/JCM.05588-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

1.  Correlation between cytotoxin production and sporulation in Clostridium difficile.

Authors:  S Kamiya; H Ogura; X Q Meng; S Nakamura
Journal:  J Med Microbiol       Date:  1992-09       Impact factor: 2.472

2.  Risk factors for early recurrent Clostridium difficile-associated diarrhea.

Authors:  A N Do; S K Fridkin; A Yechouron; S N Banerjee; G E Killgore; A M Bourgault; M Jolivet; W R Jarvis
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 4.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

5.  Recurrence of symptoms in Clostridium difficile infection--relapse or reinfection?

Authors:  M H Wilcox; W N Fawley; C D Settle; A Davidson
Journal:  J Hosp Infect       Date:  1998-02       Impact factor: 3.926

6.  A non-haemagglutinating form of Clostridium difficile toxin A.

Authors:  S Kamiya; S P Borriello
Journal:  J Med Microbiol       Date:  1992-03       Impact factor: 2.472

7.  Relapse versus reinfection with Clostridium difficile.

Authors:  G L O'Neill; M H Beaman; T V Riley
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

8.  Application of typing by pulsed-field gel electrophoresis to the study of Clostridium difficile in a neonatal intensive care unit.

Authors:  H Kato; N Kato; K Watanabe; K Ueno; H Ushijima; S Hashira; T Abe
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

9.  Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR.

Authors:  H Kato; N Kato; K Watanabe; N Iwai; H Nakamura; T Yamamoto; K Suzuki; S M Kim; Y Chong; E B Wasito
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

10.  Identification of toxigenic Clostridium difficile by the polymerase chain reaction.

Authors:  N Kato; C Y Ou; H Kato; S L Bartley; V K Brown; V R Dowell; K Ueno
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  24 in total

Review 1.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

2.  Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease.

Authors:  Anna M Seekatz; Emily Wolfrum; Christopher M DeWald; Rosemary K B Putler; Kimberly C Vendrov; Krishna Rao; Vincent B Young
Journal:  Anaerobe       Date:  2018-05-31       Impact factor: 3.331

Review 3.  Clostridioides difficile Spores: Bile Acid Sensors and Trojan Horses of Transmission.

Authors:  Aimee Shen
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

4.  Revisiting the Role of Csp Family Proteins in Regulating Clostridium difficile Spore Germination.

Authors:  Yuzo Kevorkian; Aimee Shen
Journal:  J Bacteriol       Date:  2017-10-17       Impact factor: 3.490

Review 5.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

Review 6.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

7.  Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan.

Authors:  Y Kuwata; S Tanimoto; E Sawabe; M Shima; Y Takahashi; H Ushizawa; T Fujie; R Koike; N Tojo; T Kubota; R Saito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-04       Impact factor: 3.267

8.  Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America.

Authors:  C Aguayo; R Flores; S Lévesque; P Araya; S Ulloa; J Lagos; J C Hormazabal; J Tognarelli; D Ibáñez; P Pidal; O Duery; B Olivares; J Fernández
Journal:  Epidemiol Infect       Date:  2015-02-17       Impact factor: 4.434

9.  Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples.

Authors:  Abdullah Kilic; Mohammad J Alam; Naradah L Tisdel; Dhara N Shah; Mehmet Yapar; Todd M Lasco; Kevin W Garey
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

10.  Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate.

Authors:  Tarah Lynch; Patrick Chong; Jason Zhang; Romeo Hizon; Tim Du; Morag R Graham; Daniel R Beniac; Timothy F Booth; Pamela Kibsey; Mark Miller; Denise Gravel; Michael R Mulvey
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.